On Friday, Outlook Therapeutics Inc (NASDAQ: OTLK) opened lower -21.91% from the last session, before settling in for the closing price of $1.09. Price fluctuations for OTLK have ranged from $0.79 to $8.32 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 36.59% over the past five years. Company’s average yearly earnings per share was noted 54.93% at the time writing. With a float of $28.28 million, this company’s outstanding shares have now reached $43.48 million.
Outlook Therapeutics Inc (OTLK) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Outlook Therapeutics Inc is 38.31%, while institutional ownership is 22.49%. The most recent insider transaction that took place on Sep 26 ’24, was worth 28,446. In this transaction Chief Financial Officer of this company bought 5,000 shares at a rate of $5.69, taking the stock ownership to the 5,946 shares.
Outlook Therapeutics Inc (OTLK) Latest Financial update
If we go through the results of last quarter, which was made public on 9/30/2024, the company posted -0.94 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -0.82) by -0.12. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.25 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 54.93% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 63.75% during the next five years compared to 36.59% growth over the previous five years of trading.
Outlook Therapeutics Inc (NASDAQ: OTLK) Trading Performance Indicators
Check out the current performance indicators for Outlook Therapeutics Inc (OTLK). In the past quarter, the stock posted a quick ratio of 0.54. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 25.04.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.09, a number that is poised to hit -0.28 in the next quarter and is forecasted to reach -0.79 in one year’s time.
Technical Analysis of Outlook Therapeutics Inc (OTLK)
Outlook Therapeutics Inc (NASDAQ: OTLK) saw its 5-day average volume 20.99 million, a positive change from its year-to-date volume of 1.44 million. As of the previous 9 days, the stock’s Stochastic %D was 11.53%.
During the past 100 days, Outlook Therapeutics Inc’s (OTLK) raw stochastic average was set at 2.35%, which indicates a significant increase from 2.35% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.3706 in the past 14 days, which was higher than the 0.1706 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.0376, while its 200-day Moving Average is $1.9842. Nevertheless, the first resistance level for the watch stands at $1.0008 in the near term. At $1.1504, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.2308. If the price goes on to break the first support level at $0.7708, it is likely to go to the next support level at $0.6904. The third support level lies at $0.5408 if the price breaches the second support level.
Outlook Therapeutics Inc (NASDAQ: OTLK) Key Stats
There are currently 44,420K shares outstanding in the company with a market cap of 37.81 million. Presently, the company’s annual sales total 0 K according to its annual income of -75,370 K. Last quarter, the company’s sales amounted to 1,510 K and its income totaled -20,150 K.
